NCT03423992 2021-06-15Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasXuanwu Hospital, BeijingPhase 1 Unknown100 enrolled
NCT03881774 2019-03-21Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell MalignanciesHenan Cancer HospitalPhase 1 Unknown20 enrolled